Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations-Reference-Cited by-同舟云学术

Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations

Published:2018-06-07 Issue:13 Volume:61 Page:5580-5593
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Evers Andreas¹^ORCID,Bossart Martin¹,Pfeiffer-Marek Stefania¹,Elvert Ralf¹,Schreuder Herman¹^ORCID,Kurz Michael¹,Stengelin Siegfried¹,Lorenz Martin¹,Herling Andreas¹,Konkar Anish¹,Lukasczyk Ulrike¹,Pfenninger Anja¹,Lorenz Katrin¹,Haack Torsten¹,Kadereit Dieter¹,Wagner Michael¹

Affiliation:

1. Sanofi-Aventis Deutschland GmbH, R&D, Industriepark Höchst, D-65926 Frankfurt am Main, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00292

Reference58 articles.

1. World Health Organization. Media Centre. Diabetes (Fact sheet no. 312) Available at http://www.who.int/mediacentre/factsheets/fs312/en/ [accessed 23 Jan 2018].

2. 2014 Diabetes Report Card - diabetesreportcard2014.pdf [Internet], Available at http://www.cdc.gov/diabetes/pdfs/library/diabetesreportcard2014.pdf [accessed 23 Jan 2018].

3. Nonalcoholic Steatohepatitis: Risk Factors and Diagnosis Available at http://www.medscape.com/viewarticle/731163 [accessed 23 Jan 2018].

4. Glucagon-Like Peptide-1 Formulation - the Present and Future Development in Diabetes Treatment

5. Recent Advances in GLP-1 Receptor Agonists for Use in Diabetes Mellitus

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a Novel Glucagon-like Peptide-1 (GLP-1) Analogue from Bullfrog and Investigation of Its Potential for Designing GLP-1-Based Multiagonists;Journal of Medicinal Chemistry;2023-12-20

2. Design of a Dual Agonist of Exendin-4 and FGF21 as a Potential Treatment for Type 2 Diabetes Mellitus and Obesity;Iranian Journal of Pharmaceutical Research;2023-08-09

3. Structural analysis of the dual agonism at GLP-1R and GCGR;Proceedings of the National Academy of Sciences;2023-08-07

4. Why to Study Peptides from Venomous and Poisonous Animals?;International Journal of Peptide Research and Therapeutics;2023-07-14

5. Discovery of novel OXM-based glucagon-like peptide 1 (GLP-1)/glucagon receptor dual agonists;Peptides;2023-03